UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial

European journal of surgical oncology, 2017-04, Vol.43 (4), p.672-679

2017

Volltextzugriff (PDF)

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

Cell death and differentiation, 2014-02, Vol.21 (2), p.247-257

2014

Volltextzugriff (PDF)

Transient loss of Polycomb components induces an epigenetic cancer fate

Nature (London), 2024-05, Vol.629 (8012), p.688-696

2024

Volltextzugriff (PDF)

Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Oncogene, 2017-03, Vol.36 (12), p.1745-1752

2017

Volltextzugriff (PDF)

Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer

European journal of surgical oncology, 2019-10, Vol.45 (10), p.1835-1838

2019

Volltextzugriff (PDF)

A comprehensive overview of targeted therapy in metastatic renal cell carcinoma

Current cancer drug targets, 2012-09, Vol.12 (7), p.857-872

2012

Volltextzugriff (PDF)

Arginyltransferase suppresses cell tumorigenic potential and inversely correlates with metastases in human cancers

Oncogene, 2016-08, Vol.35 (31), p.4058-4068

2016

Volltextzugriff (PDF)

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Oncogene, 2019-05, Vol.38 (22), p.4427-4428

2019

Volltextzugriff (PDF)

Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla − Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

European journal of cancer (1990), 2017-02, Vol.72, p.S1-S1

2017

Volltextzugriff (PDF)

First-principle calculations of the Berry curvature of Bloch states for charge and spin transport of electrons

Journal of physics. Condensed matter, 2012-05, Vol.24 (21), p.213202-213202

2012

Volltextzugriff (PDF)

Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer

European journal of surgical oncology, 2017-04, Vol.43 (4), p.672-679

2017

Volltextzugriff (PDF)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation

Genes, 2022-03, Vol.13 (4), p.589

2022

Volltextzugriff (PDF)

37P A consensus gene set facilitates enrichment analysis of cancer hallmarks

Annals of oncology, 2024-09, Vol.35, p.S226-S226

2024

Volltextzugriff (PDF)

Abstract P6-21-09: muTarget.com: Linking gene expression and mutation status to identify patient cohorts eligible for targeted- and immunotherapy in breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-21-09

2019

Volltextzugriff (PDF)

Abstract P5-12-12: ROCplot.org: validating predictive biomarkers of response to chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,150 breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-12-12

2019

Volltextzugriff (PDF)

ZEB1 induces the Wnt antagonist DKK1 to jointly determine poorer survival in colorectal carcinomas

European journal of cancer (1990), 2016-07, Vol.61, p.S40-S40

2016

Volltextzugriff (PDF)

82. Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer: OTOASOR Trial, a randomized, single centre, phase III, non-inferiority trial

European journal of surgical oncology, 2016-09, Vol.42 (9), p.S100-S100

2016

Volltextzugriff (PDF)

PO-357 SREBP1 drives cell-autonomous cytoskeletal changes by KRT80 remodelling during ERα breast cancer progression

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A161-A162

2018

Volltextzugriff (PDF)

1271P Identifying metabolic genes with the highest prognostic power in lung adenocarcinoma

Annals of oncology, 2023-10, Vol.34, p.S735-S736

Gyorffy, B.

2023

Volltextzugriff (PDF)

Abstract P1-07-10: Molecular subtypes of triple negative breast cancer have different sensitivity signature to established chemotherapy agents

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-07-10

2018

Volltextzugriff (PDF)

Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors

Oncogene, 2015-01, Vol.34 (3), p.373-383

2015

Volltextzugriff (PDF)

Transient loss of Polycomb components induces an epigenetic cancer fate

Nature (London), 2024-04, Vol.629 (8012), p.688-696

2024

Volltextzugriff (PDF)

Eight-year follow up results of the OTOASOR trial: The optimal treatment of the axilla – surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

Annals of oncology, 2017-09, Vol.28, p.v49-v49

2017

Volltextzugriff (PDF)

P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients

Annals of oncology, 2023-06, Vol.34, p.S53-S53

2023

Volltextzugriff (PDF)

The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1

Oncogene, 2006-03, Vol.25 (12), p.1743-1752

2006

Volltextzugriff (PDF)

1 – 25 von 527

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(479)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(514)
Deutsch
(13)
Ungarisch
(3)
Latein
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(274)
Physics
(216)
Physical Sciences
(199)
Physics, Condensed Matter
(121)
Exact Sciences And Technology
(108)
Physics, Applied
(103)
Condensed Matter: Electronic Structure, Electrical, Magnetic, And Optical Properties
(97)
Materials Science
(88)
Life Sciences & Biomedicine
(68)
Physics, Multidisciplinary
(64)
Technology
(63)
Materials Science, Multidisciplinary
(61)
Humans
(57)
Superconductivity
(33)
Female
(32)
Oncology
(31)
Magnetic Properties And Materials
(30)
Electron States
(29)
Cross-Disciplinary Physics: Materials Science; Rheology
(26)
Metals, Semimetals And Alloys
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

Transient loss of Polycomb components induces an epigenetic cancer fate

Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer

A comprehensive overview of targeted therapy in metastatic renal cell carcinoma

Arginyltransferase suppresses cell tumorigenic potential and inversely correlates with metastases in human cancers

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla − Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

First-principle calculations of the Berry curvature of Bloch states for charge and spin transport of electrons

Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation

37P A consensus gene set facilitates enrichment analysis of cancer hallmarks

Abstract P6-21-09: muTarget.com: Linking gene expression and mutation status to identify patient cohorts eligible for targeted- and immunotherapy in breast cancer

Abstract P5-12-12: ROCplot.org: validating predictive biomarkers of response to chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,150 breast cancer patients

ZEB1 induces the Wnt antagonist DKK1 to jointly determine poorer survival in colorectal carcinomas

82. Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer: OTOASOR Trial, a randomized, single centre, phase III, non-inferiority trial

PO-357 SREBP1 drives cell-autonomous cytoskeletal changes by KRT80 remodelling during ERα breast cancer progression

1271P Identifying metabolic genes with the highest prognostic power in lung adenocarcinoma

Abstract P1-07-10: Molecular subtypes of triple negative breast cancer have different sensitivity signature to established chemotherapy agents

Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors

Transient loss of Polycomb components induces an epigenetic cancer fate

Eight-year follow up results of the OTOASOR trial: The optimal treatment of the axilla – surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients

The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1

Suchergebnisse filtern